{"id":843,"date":"2010-01-14T09:55:26","date_gmt":"2010-01-14T07:55:26","guid":{"rendered":"http:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/201001"},"modified":"2017-04-01T08:53:11","modified_gmt":"2017-04-01T07:53:11","slug":"chripka-h1n1-a-cf-2","status":"publish","type":"post","link":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843","title":{"rendered":"Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za"},"content":{"rendered":"<p>V marci 2009 bol u pacientov v Mexiku identifikovan\u00fd nov\u00fd kme\u0148 v\u00edrusu chr\u00edpky typu A, ktor\u00fd sa r\u00fdchlo za\u010dal \u0161\u00edri\u0165 po celom svete. WHO tento stav ozna\u010dila za svetov\u00fa chr\u00edpkov\u00fa pand\u00e9miu, prv\u00fa od r. 1968. Po\u010diato\u010dn\u00e9 obavy z vysokej \u00famrtnosti (ktor\u00e9 sa nesk\u00f4r nepotvrdili) viedli k ve\u013ekej pozornosti venovanej \u0161\u00edreniu v\u00edrusu. Pre nov\u00fd kme\u0148 sa za\u010dalo pou\u017e\u00edva\u0165 viacero n\u00e1zvov, ako \u201cprasacia chr\u00edpka\u201d, \u201cnov\u00e1 chr\u00edpka\u201d alebo \u201cH1N1\u201d resp. \u201cA\/H1N1\u201d.<\/p>\n<p>Ofici\u00e1lny vedeck\u00fd n\u00e1zov nov\u00e9ho chr\u00edpkov\u00e9ho kme\u0148a je \u201cA\/California\/07\/2009 (H1N1)\u201d. Svojou genetickou \u0161trukt\u00farou nie je kme\u0148 H1N1 v\u00fdnimo\u010dn\u00fd. \u0160pecifikom je, \u017ee obsahuje fragmenty RNA poch\u00e1dzaj\u00face z SIV (Swine Influenza Virus) na z\u00e1klade \u010doho bolo aj odvoden\u00e9 pomenovanie \u201cprasacia chr\u00edpka\u201d. Pr\u00edpady ke\u010f sa v jednom v\u00edruse prirodzen\u00fdmi procesmi skombinuj\u00fa genetick\u00e9 fragmenty r\u00f4znych v\u00edrusov s\u00fa pomerne be\u017en\u00e9 a dobre zdokumentovan\u00e9. \u0160t\u00fadia Centers for Disease Control and Prevention (CDC) zistila \u017ee na rozdiel od det\u00ed\u00a0 niektor\u00ed dospel\u00ed, najm\u00e4 nad 60 rokov, maj\u00fa vo\u010di H1N1 ur\u010dit\u00fd stupe\u0148 imunity, \u010do nazna\u010duje genetick\u00fa a imunog\u00e9nnu podobnos\u0165 H1N1 s kme\u0148mi chr\u00edpky z pred nieko\u013ek\u00fdch desiatok rokov. Za jedno z riz\u00edk sa st\u00e1le pova\u017euje mo\u017enos\u0165 vzniku nov\u00fdch mut\u00e1cii H1N1, ktor\u00e9 by mohli ma\u0165 z\u00e1va\u017enej\u0161ie klinick\u00e9 d\u00f4sledky.<\/p>\n<p>Klinick\u00e9 prejavy H1N1 s\u00fa v mnohom podobn\u00e9 sez\u00f3nnej chr\u00edpke a zah\u0155\u0148aj\u00fa najm\u00e4 ka\u0161e\u013e, hor\u00fa\u010dku, boles\u0165 svalov, mal\u00e1tnos\u0165, boles\u0165 hlavy, \u010falej sa m\u00f4\u017eu menej \u010dasto vyskytn\u00fa\u0165 nauzea, vracanie a hna\u010dka. Vo v\u0161eobecnosti m\u00e1 H1N1 v\u00e4\u010d\u0161inou mierny priebeh podobn\u00fd sez\u00f3nnej chr\u00edpke. Rovnako po\u010det \u00famrt\u00ed nie je vy\u0161\u0161\u00ed ako pri sez\u00f3nnej chr\u00edpke (pribli\u017ene 0,1 %). Oproti sez\u00f3nnej chr\u00edpke s\u00fa v\u0161ak ale viac ohrozen\u00e9 niektor\u00e9 skupiny pacientov, pri ktor\u00fdch je nebezpe\u010denstvo zdravotn\u00fdch komplik\u00e1cii, odli\u0161n\u00e9 ako pri sez\u00f3nnej chr\u00edpke.<\/p>\n<p>WHO pova\u017euje za rizikov\u00e9 skupiny:<\/p>\n<ul>\n<li>Novorodenci a deti (najm\u00e4 mlad\u0161ie ako 2 roky)<\/li>\n<li>Tehotn\u00e9 \u017eeny<\/li>\n<li>Osoby s chronick\u00fdm ochoren\u00edm p\u013e\u00fac, srdca, metabolick\u00fdmi poruchami (najm\u00e4 diabetes), obli\u010diek, pe\u010dene, niektor\u00fdmi neurologick\u00fdmi ochoreniami a zn\u00ed\u017eenou imunitou<\/li>\n<li>Deti u\u017e\u00edvaj\u00face aspir\u00edn (kyselinu acetylsalicylovu)<\/li>\n<li>Osoby star\u0161ie ako 65 rokov<\/li>\n<\/ul>\n<p>V\u00fdrazn\u00fdm rizikom H1N1 je skuto\u010dnos\u0165 \u017ee m\u00f4\u017ee vies\u0165 k r\u00fdchlemu rozvoju z\u00e1palu p\u013e\u00fac (pneum\u00f3nii) a\u017e k p\u013e\u00facnemu (pulmon\u00e1rnemu) zlyhaniu. Ohrozen\u00fd rozvojom p\u013e\u00facnych komplik\u00e1cii s\u00fa pacienti ktor\u00fd maj\u00fa in\u00e9 chronick\u00e9 ochorenie p\u013e\u00fac. To bolo dokumentovan\u00e9 napr\u00edklad v pr\u00edpade astmy, chronickej ob\u0161truk\u010dnej choroby p\u013e\u00fac. Nie s\u00fa zatia\u013e v\u0161eobecne zn\u00e1me pr\u00edpady komplik\u00e1cii pri cystickej fibr\u00f3ze ale na z\u00e1klade s\u00fa\u010dasn\u00fdch poznatkov sa samozrejme t\u00e1to mo\u017enos\u0165 predpoklad\u00e1. V pr\u00edpade rozvoja komplikovan\u00e9ho z\u00e1palu p\u013e\u00fac je potrebn\u00e9 o\u0161etrenie na jednotke intenz\u00edvnej starostlivosti a v\u00fdrazne sa zvy\u0161uje riziko smrti.<\/p>\n<p>Je ist\u00e9 \u017ee od vypuknutia pand\u00e9mie na chr\u00edpku H1N1 ochoreli mili\u00f3ny \u013eud\u00ed. Vytvorenie presnej\u0161\u00edch odhadov je \u010dasto komplikovan\u00e9, ke\u010f\u017ee v\u00e4\u010d\u0161ina \u013eud\u00ed nevyh\u013ead\u00e1 medic\u00ednske o\u0161etrenie, pokia\u013e si to ich zdravotn\u00fd stav nevy\u017eaduje. Na spo\u013eahliv\u00e9 potvrdenie \u017ee pr\u00ed\u010dinou ochorenia je H1N1 je potrebn\u00e1 vy\u0161etrenie vzoriek reverzne transkribovanou polymer\u00e1zovou re\u0165azovou reakciou, ktor\u00e9 sa rutinne nikde na svete nevykon\u00e1va. <a href=\"http:\/\/www.cdc.gov\/h1n1flu\/estimates_2009_h1n1.htm\">Odhad CDC<\/a> predpoklad\u00e1 \u017ee (do konca okt\u00f3bra 2009) chr\u00edpku H1N1 v USA prekonalo 22 mili\u00f3nov \u013eud\u00ed a odhadovan\u00fd po\u010det \u00famrt\u00ed je 3900, pri\u010dom po\u010det laborat\u00f3rne potvrden\u00fdch \u00famrt\u00ed je 2240 (do 17. okt\u00f3bra 2009). Predpokladan\u00fd po\u010det \u00famrt\u00ed v Eur\u00f3pe do konca novembra 2009 je okolo 700, pri\u010dom najviac zasiahnut\u00fdmi Eur\u00f3pskymi krajinami s\u00fa Ve\u013ek\u00e1 Brit\u00e1nia,\u00a0 \u0160panielsko a Franc\u00fazsko (pod\u013ea po\u010dtu \u00famrt\u00ed). V\u00e4\u010d\u0161ina odborn\u00edkov predpoklad\u00e1 \u017ee H1N1 chr\u00edpka dosiahne svoj vrchol na severnej pologuli v po\u010dte ochoren\u00ed po\u010das zimy 2009\/2010. Pod\u013ea s\u00fa\u010dasn\u00fdch \u00fadajov (december 2009) sa zd\u00e1 \u017ee po\u010det nov\u00fdch pr\u00edpadov v USA kles\u00e1 (aj v s\u00favislosti s o\u010dkovan\u00edm), zatia\u013e \u010do v Eur\u00f3pe sa st\u00e1le zvy\u0161uje.<\/p>\n<h4><strong>Zabr\u00e1nenie prenosu v\u00edrusu<\/strong><\/h4>\n<p>V\u00edrus H1N1 sa \u0161\u00edri z \u010dloveka na \u010dloveka kvap\u00f4\u010dkovou infekciou (rovnako ako sez\u00f3nna chr\u00edpka), najm\u00e4 pri ka\u0161li, k\u00fdchan\u00ed. Na zn\u00ed\u017eenie rizika n\u00e1kazy s\u00fa \u00fa\u010dinn\u00e9 najm\u00e4 tieto prevent\u00edvne opatrenia:<\/p>\n<ul>\n<li>\u010cast\u00e9 um\u00fdvanie r\u00fak mydlom, alebo alkoholov\u00fdm g\u00e9lom.<\/li>\n<li>Vyh\u00fdbanie sa dotyku o\u010d\u00ed, \u00fast, nosnej sliznice.<\/li>\n<li>Riziko n\u00e1kazy je vy\u0161\u0161ie na miestach kde sa koncentruj\u00fa \u013eudia (mestsk\u00e1 hromadn\u00e1 doprava, \u010dak\u00e1re\u0148 lek\u00e1ra, spolo\u010densk\u00e9 akcie a pod.).<\/li>\n<li>R\u00fa\u0161ka neochr\u00e1ni pred infekciou, jej v\u00fdznam je iba pre chor\u00fdch t\u00fdm \u017ee zn\u00ed\u017ei mno\u017estvo v\u00edrusov ktor\u00e9 sa ka\u0161\u013eom a k\u00fdchan\u00edm dostan\u00fa do okolia a t\u00fdm m\u00f4\u017ee zn\u00ed\u017ei\u0165 pravdepodobnos\u0165 nakazi\u0165 \u013eud\u00ed v okol\u00ed. R\u00fa\u0161ka sa odpor\u00fa\u010da nasadi\u0165 chor\u00fdm pokia\u013e s\u00fa v kontakte s \u010fal\u0161\u00edmi osobami, ktor\u00e9 by mohli nakazi\u0165.<\/li>\n<li>Zabr\u00e1ni\u0165 vd\u00fdchnutiu \u010dast\u00edc ktor\u00e9 m\u00f4\u017eu obsahova\u0165 v\u00edrusy s\u00fa schopn\u00e9 respir\u00e1tory. Vzh\u013eadom na v\u0161eobecne n\u00edzke riziko n\u00e1kazy pou\u017eitie respir\u00e1tora <a href=\"http:\/\/www.cdc.gov\/h1n1flu\/masks.htm\">CDC odpor\u00fa\u010da<\/a> jedine u os\u00f4b ktor\u00e9 o\u0161etruj\u00fa chor\u00fdch s v\u00edrusom H1N1.<\/li>\n<li>Niektor\u00e9 \u0161t\u00e1ty (napr. \u010c\u00edna, Rusko) zaviedli prechodn\u00e9 opatrenia obmedzuj\u00face cestovanie, zah\u0155\u0148aj\u00face napr. povinn\u00fa karant\u00e9nu pri pr\u00edznakoch chr\u00edpky po pricestovan\u00ed zo zahrani\u010dia, alebo vyzvali ob\u010danov aby necestovali do kraj\u00edn viac postihnut\u00fdch H1N1 pand\u00e9miou. Tak\u00e9to opatrenia s\u00fa v rozpore so stanoviskom WHO, ktor\u00e1 neodpor\u00fa\u010da \u017eiadne obmedzenia medzin\u00e1rodn\u00e9ho pohybu os\u00f4b.<\/li>\n<\/ul>\n<h4><strong>O\u010dkovanie<\/strong><\/h4>\n<p>O\u010dkovanie je najspo\u013eahlivej\u0161\u00edm sp\u00f4sobom ochrany proti H1N1. Pod\u013ea klinick\u00fdch \u0161t\u00fadii by mala by\u0165 \u00fa\u010dinnos\u0165 ochrany okolo 99 % (pri sez\u00f3nnej chr\u00edpke sa uv\u00e1dza v\u00e4\u010d\u0161inou \u00fa\u010dinnos\u0165 okolo 70 %). O\u010dkovanie prin\u00e1\u0161a niektor\u00e9 mo\u017en\u00e9 ved\u013eaj\u0161ie \u00fa\u010dinky, ktor\u00e9 v\u00e4\u010d\u0161inou nie s\u00fa z\u00e1va\u017en\u00e9. Po vypuknut\u00ed H1N1 pand\u00e9mie sa objavili tvrdenia \u017ee o\u010dkovanie proti sez\u00f3nnej chr\u00edpke by malo ma\u0165 do ur\u010ditej miery ochrann\u00fd \u00fa\u010dinok vo\u010di H1N1. \u0160t\u00fadie CDC tieto tvrdenia vyvr\u00e1tili, pod\u013ea t\u00fdchto zisten\u00ed \u013eudia o\u010dkovan\u00fd vo\u010di sez\u00f3nnej chr\u00edpke nemaj\u00fa \u017eiadne H1N1 protil\u00e1tky.<\/p>\n<p>H1N1 o\u010dkovacie l\u00e1tky s\u00fa dostupn\u00e9 na trhu v USA od novembra 2009. V tejto s\u00favislosti CDC vydala odpor\u00fa\u010dania ktor\u00e9 skupiny by mali by\u0165 prednostne o\u010dkovan\u00e9. Okrem in\u00fdch skup\u00edn zah\u0155\u0148a pacientov s chronick\u00fdmi ochoreniami pri ktor\u00fdch m\u00f4\u017ee chr\u00edpka sp\u00f4sobi\u0165 medic\u00ednske komplik\u00e1cie. Podobn\u00e9 odpor\u00fa\u010danie vydal aj National Health Service vo Ve\u013ekej Brit\u00e1nii, kde odpor\u00fa\u010da okrem in\u00fdch o\u010dkovanie pre osoby s chronick\u00fdmi p\u013e\u00facnymi ochoreniami. Celkovo bolo do konca novembra celosvetovo zao\u010dkovan\u00fdch pribli\u017ene 65 mili\u00f3nov \u013eud\u00ed. Ud\u00e1va sa \u017ee svetov\u00e1 kapacita na produkciu proti chr\u00edpkov\u00fdch vakc\u00edn je 3,5 miliardy d\u00e1vok.<\/p>\n<p>European Medicines Agency schv\u00e1lila pre pou\u017e\u00edvanie v Eur\u00f3pe nasledovn\u00e9 vakc\u00edny vo\u010di H1N1:<\/p>\n<ul>\n<li><a href=\"http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/celvapan\/emea-combined-h982sk.pdf\">Celvapan<\/a> (Baxter)<\/li>\n<li>Focetria (Novartis)<\/li>\n<li><a href=\"http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/pandemrix\/emea-combined-h832sk.pdf\">Pandemrix<\/a> (GSK)<\/li>\n<\/ul>\n<p>Slovensk\u00e1 vl\u00e1da nak\u00fapila vakc\u00ednu Panenza v\u00fdrobcu Sanofi-Pasteur, ktor\u00e1 je taktie\u017e \u0161iroko pou\u017e\u00edvan\u00e1 tak v mnoh\u00fdch Eur\u00f3pskych krajin\u00e1ch ako aj v USA. Slovensk\u00e9 ministerstvo zdravotn\u00edctva v\u0161ak nebolo schopn\u00e9 zabezpe\u010di\u0165 o\u010dkovaciu l\u00e1tku v\u010das a dodnes (janu\u00e1r 2010) s\u00fa z\u00e1sadn\u00e9 probl\u00e9my s distrib\u00faciu vakc\u00edny, \u010do zabr\u00e1nilo mnoh\u00fdm \u013eu\u010fom aj v rizikov\u00fdch kateg\u00f3ri\u00e1ch da\u0165 sa zao\u010dkova\u0165.<\/p>\n<p>Jedin\u00fd rozdiel vo vakc\u00edne H1N1 a sez\u00f3nnej chr\u00edpky je v obsahu antig\u00e9nov (v\u00edrusov\u00fdch zlo\u017eiek ktor\u00e9 ved\u00fa k tvorbe protil\u00e1tok a vzniku \u0161pecifickej imunity), nel\u00ed\u0161i sa ani technol\u00f3giou v\u00fdroby, ani v\u0161eobecn\u00fdmi z\u00e1sadami pri o\u010dkovan\u00ed.<\/p>\n<p>Opatrn\u00fd by mali by\u0165 \u013eudia s alergiou na vaje\u010dn\u00fd \u017e\u013atok, kv\u00f4li mo\u017enosti alergick\u00fdch reakcii. Z\u00e1va\u017en\u00fdm ale ve\u013emi zriedkav\u00fdm (jeden pr\u00edpad na mili\u00f3n o\u010dkovan\u00ed) stavom ktor\u00fd sa m\u00f4\u017ee sp\u00e1ja\u0165 s o\u010dkovan\u00edm je Gullian-Barre syndr\u00f3m (GBS). Patofyziologick\u00fdm mechanizmom GBS je auto imunitn\u00e9 po\u0161kodenie nervov\u00e9ho tkaniva, ktor\u00e9 m\u00f4\u017ee vies\u0165 a\u017e ku smrti. Vz\u0165ah medzi o\u010dkovan\u00edm proti chr\u00edpke a GBS nie je doteraz celkom objasnen\u00fd, preto\u017ee je potvrden\u00e9 \u017ee GBS m\u00f4\u017ee vyvola\u0165 samotn\u00e1 chr\u00edpka a riziko \u017ee chr\u00edpka vyvol\u00e1 GBS je vy\u0161\u0161ie ako \u017ee ho vyvol\u00e1 o\u010dkovanie. Medzi pomerne \u010dast\u00e9 ne\u017eiaduce \u00fa\u010dinky be\u017en\u00e9 pri o\u010dkovan\u00ed, ktor\u00e9 sa vyskytuj\u00fa aj pri H1N1 o\u010dkovan\u00ed a nie s\u00fa nijako z\u00e1va\u017en\u00e9 patria tria\u0161ka, za\u010dervenanie a opuch v mieste vpichu, mal\u00e1tnos\u0165. V s\u00favislosti s bezpe\u010dnos\u0165ou o\u010dkovania sa v tla\u010di a na internete objavilo viacero zav\u00e1dzaj\u00facich tvrden\u00ed, spochyb\u0148uj\u00facich bezpe\u010dnos\u0165 vakc\u00edn. Pr\u00edkladom je napr\u00edklad \u00famrtie nieko\u013ek\u00fdch pacientov vo \u0160v\u00e9dsku nieko\u013eko dn\u00ed po o\u010dkovan\u00ed, ni\u010d v\u0161ak nenasved\u010duje tomu \u017ee by o\u010dkovanie malo by\u0165 pr\u00ed\u010dinou \u00famrtia a jednalo sa vo v\u0161etk\u00fdch pr\u00edpadoch o pacientov s v\u00e1\u017enymi \u010fal\u0161\u00edmi ochoreniami (ktor\u00e9 zrejme boli pr\u00ed\u010dinu smrti) a v pokro\u010dilom veku.\u00a0 H1N1 vakc\u00edny boli podroben\u00e9 vedeckej anal\u00fdze a schv\u00e1leniu Eur\u00f3pskych a Americk\u00fdch regula\u010dn\u00fdch \u00faradov a je mo\u017en\u00e9 pova\u017eova\u0165 ich za plne bezpe\u010dn\u00e9.<\/p>\n<h4><strong>Antivirotik\u00e1<\/strong><\/h4>\n<p>Na trhu s\u00fa dva antivirotick\u00e9 lieky \u00fa\u010dinn\u00e9 vo\u010di v\u00edrusu chr\u00edpky, vr\u00e1tane kme\u0148a H1N1 a to <a href=\"http:\/\/www.nobelplus.sk\/web\/humanne-lieky\/spc\/tamiflu-spc-25647.html\">Tamiflu<\/a> (oseltamivir) a <a href=\"http:\/\/www.nobelplus.sk\/web\/humanne-lieky\/spc\/relenza-5-mg-davka-spc-22174.html\">Relenza<\/a> (zanamivir). Tieto lieky by sa mali u\u017e\u00edva\u0165 iba s vedom\u00edm a na z\u00e1klade odpor\u00fa\u010dania o\u0161etruj\u00faceho lek\u00e1ra. Pod\u013ea odpor\u00fa\u010dan\u00ed WHO lie\u010dba antivirotikami sa odpor\u00fa\u010da iba u pacientov ktor\u00fd maj\u00fa komplik\u00e1cie spojen\u00e9 s H1N1 infekciou, alebo je u nich vzh\u013eadom na in\u00e9 chronick\u00e9 ochorenia zv\u00fd\u0161en\u00e1 pravdepodobnos\u0165 v\u00fdskytu komplik\u00e1cii. Za liek vo\u013eby pri komplik\u00e1ci\u00e1ch sa pova\u017euje oseltamivir (tamiflu). Podanie antivirot\u00edk v indikovan\u00fdch pr\u00edpadoch mus\u00ed by\u0165 \u010do najskor\u0161ie, ke\u010f\u017ee \u00fa\u010dinkuj\u00fa vo f\u00e1ze mno\u017eenia v\u00edrusu, teda najm\u00e4 po prepuknut\u00ed ochorenia. Oseltamivir aj zanamivir je mo\u017en\u00e9 pou\u017e\u00edva\u0165 aj prevent\u00edvne, aj ke\u010f sa to za be\u017en\u00fdch okolnost\u00ed neodpor\u00fa\u010da (do \u00favahy m\u00f4\u017ee prich\u00e1dza\u0165 napr. u os\u00f4b o\u0161etruj\u00faceho chor\u00e9ho s H1N1).<\/p>\n<p>V pr\u00edpade ak sa stav pacienta napriek podaniu oseltamiviru alebo zanamiviru na\u010falej zhor\u0161uje je mo\u017en\u00e9 zv\u00e1\u017ei\u0165 podanie in\u00fdch antivirot\u00edk ako napr. ribavirinu, peramiviru. Bolo hl\u00e1sen\u00fdch nieko\u013eko pr\u00edpadov rezistencie v\u00edrusu H1N1 vo\u010di oseltamiviru, okrem toho H1N1 kme\u0148 je rezistentn\u00fd vo\u010di antivirotik\u00e1m amantad\u00ednu a rimantad\u00ednu. Jednou z \u010dast\u00fdch komplik\u00e1cii pneum\u00f3nie pri H1N1 s\u00fa sekund\u00e1rne bakteri\u00e1lne infekcie, \u010dasto bakt\u00e9riou <em>Staphyloccocus aureus<\/em>. Tak\u00e1to kombinovan\u00e1 infekcia m\u00f4\u017ee by\u0165 mimoriadne nebezpe\u010dn\u00e1, najm\u00e4 v s\u00favislosti s vysokou mierou antibiotickej rezistencie <em>Staphylococcus aureus<\/em>. Preto je potrebn\u00e9 v\u010dasn\u00e9 nasadenie antibiot\u00edk pod\u013ea v\u0161eobecn\u00fdch odpor\u00fa\u010dan\u00ed a v\u00fdvoja zdravotn\u00e9ho stavu. Profylaktick\u00e9 u\u017e\u00edvanie antibiot\u00edk sa ale neodpor\u00fa\u010da.<\/p>\n<h4><strong>Podporn\u00e1 lie\u010dba<\/strong><\/h4>\n<p>Vo v\u00e4\u010d\u0161ine pr\u00edpadov nie je pri H1N1 potrebn\u00e1 hospitaliz\u00e1cia ani podanie antivirot\u00edk a priebeh ochorenia je mierny. Za t\u00fdchto okolnost\u00ed sa uplat\u0148uje lie\u010dba ako pri sez\u00f3nnej chr\u00edpke. D\u00f4le\u017eit\u00e9 je zabezpe\u010di\u0165 dostatok tekut\u00edn. Zv\u00fd\u0161en\u00e1 teplota je \u010dast\u00fdm pr\u00edznakom, ak prevy\u0161uje 38 \u00b0C odpor\u00fa\u010da sa pou\u017eitie antipyret\u00edk ako paracetamol, pr\u00edpadne ibuprof\u00e9nu ktor\u00fd m\u00e1 aj protiz\u00e1palov\u00fd \u00fa\u010dinok. Alternat\u00edvne sa m\u00f4\u017ee pou\u017ei\u0165 kyselina salicylova (acylpyr\u00edn, aspir\u00edn) okrem det\u00ed pod 12 rokov a tehotn\u00fdch \u017eien. Na trhu s\u00fa tie\u017e kombinovan\u00e9 pr\u00edpravky s paracetamolom, vitam\u00ednom C a fenylefr\u00ednom s komplexnej\u0161\u00edm \u00fa\u010dinkom tlmiacich pr\u00edznaky chr\u00edpky.<\/p>\n<p>Alternat\u00edvou s\u00fa pr\u00edrodn\u00e9 lie\u010div\u00e1 resp. ich kombin\u00e1cie s vitam\u00ednmi,<br \/>\nminer\u00e1lmi. Pri respira\u010dn\u00fdch infekci\u00e1ch sa z vitam\u00ednov odpor\u00fa\u010da u\u017e\u00edva\u0165 predov\u0161etk\u00fdm vitam\u00edn C a z miner\u00e1lov zinok. Vedecky potvrden\u00fd imunostimula\u010dn\u00fd \u00fa\u010dinok maj\u00fa extrakty z echinacei, ktor\u00fdch u\u017e\u00edvanie vedie k skr\u00e1teniu trvania prejavov chr\u00edpky a aj \u010fal\u0161\u00edch respira\u010dn\u00fdch ochoren\u00ed. Niektor\u00e9 \u010fal\u0161ie pr\u00edrodn\u00e9 lie\u010div\u00e1 tradi\u010dne pou\u017e\u00edvan\u00e9 pri lie\u010dbe chr\u00edpky s\u00fa napr. kvercet\u00edn s antioxido\u010dn\u00fdmi \u00fa\u010dinkami, cesnak a z\u00e1zvor ktor\u00e9 maj\u00fa antibakteri\u00e1lny a antivirotick\u00fd \u00fa\u010dinok. Jedn\u00fdm z kvalitn\u00fdch pr\u00edpravkov ktor\u00fd obsahuje tieto pr\u00edrodn\u00e9 zlo\u017eky, vitam\u00edny a miner\u00e1ly je napr\u00edklad <a href=\"http:\/\/www.medart.sk\/buxus\/generate_page.php?page_id=74543\">Cold &amp; Flu Formula<\/a>, ktor\u00fd je odpor\u00fa\u010dan\u00fd tak pri ak\u00fatnych pr\u00edznakoch ako aj dlhodobo na zn\u00ed\u017eenie rizika ochorenia.<\/p>\n<h4><strong>Z\u00e1ver<\/strong><\/h4>\n<p>Cystic Fibrosis Foundation (CFF) publikovala stru\u010dn\u00e9 <a href=\"http:\/\/www.cff.org\/CheckOut\/What-People-With-CF-Should-Know-About-the-Flu.cfm\">odpor\u00fa\u010dania<\/a> pre \u013eud\u00ed s CF v s\u00favislosti s H1N1. CF pacientov zara\u010fuje medzi rizikov\u00fa skupinu a odpor\u00fa\u010da o\u010dkovanie. Popri o\u010dkovan\u00ed je vhodn\u00e9 dba\u0165 na prevent\u00edvne opatrenia na zabr\u00e1nenie n\u00e1kazy ako um\u00fdvanie r\u00fak, vyh\u00fdbanie sa kontaktu s chor\u00fdmi. V pr\u00edpade ochorenia okam\u017eite vyh\u013eada\u0165 medic\u00ednsku pomoc a pod\u013ea odpor\u00fa\u010dania lek\u00e1ra indik\u00e1cia antivirotickej lie\u010dby (tamiflu). Tieto odpor\u00fa\u010dania m\u00f4\u017eu by\u0165 zhrnut\u00edm toho \u010do vypl\u00fdva pre \u013eud\u00ed s cystickou fibr\u00f3zou z pand\u00e9mie H1N1. O\u010dkovanie sa v\u0161eobecne odpor\u00fa\u010da pri riziku komplik\u00e1cii spojen\u00fdch s pr\u00edtomnos\u0165ou chronick\u00e9ho ochorenia p\u013e\u00fac. Mo\u017en\u00fdm argumentom proti o\u010dkovaniu by mohlo by\u0165 \u017ee H1N1 m\u00e1 v\u00e4\u010d\u0161inou mierny priebeh podobn\u00fd sez\u00f3nnej chr\u00edpke. Treba si ale uvedomi\u0165 aj rozdiel ktor\u00fd m\u00f4\u017ee by\u0165 e\u0161te v\u00fdznamnej\u0161\u00ed pri CF a to riziko r\u00fdchleho n\u00e1stupu z\u00e1palu p\u013e\u00fac a pulmon\u00e1rneho zlyhania. V pr\u00edpade t\u00fdchto pr\u00edznakov je nevyhnutn\u00e1 hospitaliz\u00e1cia. Na druhej strane je pote\u0161ite\u013en\u00e9 \u017ee sa nepotvrdili p\u00f4vodn\u00e9 obavy o svetovej pand\u00e9mii s vysokou \u00famrtnos\u0165ou. Pri re\u0161pektovan\u00ed tu uveden\u00fdch odpor\u00fa\u010dan\u00ed a sledovan\u00ed v\u00fdvoja nie je nijako potrebn\u00e9 meni\u0165 svoj \u017eivotn\u00fd \u0161t\u00fdl, alebo ma\u0165 prehnan\u00e9 obavy.<\/p>\n<h4><strong>\u010eal\u0161ie inform\u00e1cie<br \/>\n<\/strong><\/h4>\n<p>Pre \u0161irok\u00fa verejnos\u0165 European Center for Disease Prevention and Control zriadilo v\u0161eobecn\u00fa <a href=\"http:\/\/www.ecdc.europa.eu\/en\/healthtopics\/Pages\/Influenza_A(H1N1)_Outbreak.aspx\">informa\u010dn\u00fa str\u00e1nku o chr\u00edpke H1N1<\/a>. Podobn\u00fa <a href=\"http:\/\/web.archive.org\/web\/20160921004233\/http:\/\/www.flu.gov:80\/\">str\u00e1nku<\/a> zriadil v USA U.S. Department of Health &amp; Human Services. WHO publikovala s\u00fabor odpor\u00fa\u010dan\u00ed pre lie\u010dbu chor\u00fdch s H1N1: <a href=\"http:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/clinical_management_h1n1.pdf\">Clinical management of human infection with pandemic (H1N1) 2009: revised guidence<\/a> .<\/p>\n","protected":false},"excerpt":{"rendered":"<p>V marci 2009 bol u pacientov v Mexiku identifikovan&yacute; nov&yacute; kme&#328; v&iacute;rusu chr&iacute;pky typu A, ktor&yacute; sa r&yacute;chlo za&#269;al &scaron;&iacute;ri&#357; po celom svete. WHO tento stav ozna&#269;ila za svetov&uacute; chr&iacute;pkov&uacute; pand&eacute;miu, prv&uacute; od r. 1968. Po&#269;iato&#269;n&eacute; obavy z vysokej &uacute;mrtnosti &hellip; <a href=\"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843\">Continued<\/a><\/p>\n","protected":false},"author":7,"featured_media":1600,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"kt_blocks_editor_width":"","footnotes":""},"categories":[3],"tags":[132],"class_list":["post-843","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lieky-a-liecba","tag-h1n1"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za - Slan\u00e9 deti<\/title>\n<meta name=\"description\" content=\"V marci 2009 bol u pacientov v Mexiku identifikovan\u00fd nov\u00fd kme\u0148 v\u00edrusu chr\u00edpky typu A, - \u201cprasacia chr\u00edpka\u201d, \u201cnov\u00e1 chr\u00edpka\u201d alebo \u201cH1N1\u201d resp. \u201cA\/H1N1\u201d.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za - Slan\u00e9 deti\" \/>\n<meta property=\"og:description\" content=\"V marci 2009 bol u pacientov v Mexiku identifikovan\u00fd nov\u00fd kme\u0148 v\u00edrusu chr\u00edpky typu A, - \u201cprasacia chr\u00edpka\u201d, \u201cnov\u00e1 chr\u00edpka\u201d alebo \u201cH1N1\u201d resp. \u201cA\/H1N1\u201d.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843\" \/>\n<meta property=\"og:site_name\" content=\"Slan\u00e9 deti\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/slanedeti\" \/>\n<meta property=\"article:published_time\" content=\"2010-01-14T07:55:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-04-01T07:53:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2013\/07\/logo_CB-e1446396108362.png\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gallagher\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gallagher\" \/>\n\t<meta name=\"twitter:label2\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data2\" content=\"13 min\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843\"},\"author\":{\"name\":\"Gallagher\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/05d1c3faf9ab837ae66dc01f490cedaa\"},\"headline\":\"Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za\",\"datePublished\":\"2010-01-14T07:55:26+00:00\",\"dateModified\":\"2017-04-01T07:53:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843\"},\"wordCount\":2537,\"image\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logo_CB-e1446396108362.png\",\"keywords\":[\"H1N1\"],\"articleSection\":[\"Lieky a lie\u010dba\"],\"inLanguage\":\"sk-SK\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843\",\"name\":\"Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za - Slan\u00e9 deti\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logo_CB-e1446396108362.png\",\"datePublished\":\"2010-01-14T07:55:26+00:00\",\"dateModified\":\"2017-04-01T07:53:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/05d1c3faf9ab837ae66dc01f490cedaa\"},\"description\":\"V marci 2009 bol u pacientov v Mexiku identifikovan\u00fd nov\u00fd kme\u0148 v\u00edrusu chr\u00edpky typu A, - \u201cprasacia chr\u00edpka\u201d, \u201cnov\u00e1 chr\u00edpka\u201d alebo \u201cH1N1\u201d resp. \u201cA\\\/H1N1\u201d.\",\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/chripka-h1n1-a-cf-2\\\/843#primaryimage\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logo_CB-e1446396108362.png\",\"contentUrl\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/wp-content\\\/uploads\\\/2013\\\/07\\\/logo_CB-e1446396108362.png\",\"width\":350,\"height\":350},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#website\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/\",\"name\":\"Slan\u00e9 deti\",\"description\":\"Inform\u00e1cie o cystickej fibr\u00f3ze\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/#\\\/schema\\\/person\\\/05d1c3faf9ab837ae66dc01f490cedaa\",\"name\":\"Gallagher\",\"url\":\"https:\\\/\\\/slanedeti.sk\\\/cms\\\/author\\\/gallagher\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za - Slan\u00e9 deti","description":"V marci 2009 bol u pacientov v Mexiku identifikovan\u00fd nov\u00fd kme\u0148 v\u00edrusu chr\u00edpky typu A, - \u201cprasacia chr\u00edpka\u201d, \u201cnov\u00e1 chr\u00edpka\u201d alebo \u201cH1N1\u201d resp. \u201cA\/H1N1\u201d.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843","og_locale":"sk_SK","og_type":"article","og_title":"Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za - Slan\u00e9 deti","og_description":"V marci 2009 bol u pacientov v Mexiku identifikovan\u00fd nov\u00fd kme\u0148 v\u00edrusu chr\u00edpky typu A, - \u201cprasacia chr\u00edpka\u201d, \u201cnov\u00e1 chr\u00edpka\u201d alebo \u201cH1N1\u201d resp. \u201cA\/H1N1\u201d.","og_url":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843","og_site_name":"Slan\u00e9 deti","article_publisher":"http:\/\/www.facebook.com\/slanedeti","article_published_time":"2010-01-14T07:55:26+00:00","article_modified_time":"2017-04-01T07:53:11+00:00","og_image":[{"width":350,"height":350,"url":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2013\/07\/logo_CB-e1446396108362.png","type":"image\/png"}],"author":"Gallagher","twitter_misc":{"Autor":"Gallagher","Predpokladan\u00fd \u010das \u010d\u00edtania":"13 min\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843#article","isPartOf":{"@id":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843"},"author":{"name":"Gallagher","@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/05d1c3faf9ab837ae66dc01f490cedaa"},"headline":"Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za","datePublished":"2010-01-14T07:55:26+00:00","dateModified":"2017-04-01T07:53:11+00:00","mainEntityOfPage":{"@id":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843"},"wordCount":2537,"image":{"@id":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843#primaryimage"},"thumbnailUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2013\/07\/logo_CB-e1446396108362.png","keywords":["H1N1"],"articleSection":["Lieky a lie\u010dba"],"inLanguage":"sk-SK"},{"@type":"WebPage","@id":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843","url":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843","name":"Chr\u00edpka H1N1 a cystick\u00e1 fibr\u00f3za - Slan\u00e9 deti","isPartOf":{"@id":"https:\/\/slanedeti.sk\/cms\/#website"},"primaryImageOfPage":{"@id":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843#primaryimage"},"image":{"@id":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843#primaryimage"},"thumbnailUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2013\/07\/logo_CB-e1446396108362.png","datePublished":"2010-01-14T07:55:26+00:00","dateModified":"2017-04-01T07:53:11+00:00","author":{"@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/05d1c3faf9ab837ae66dc01f490cedaa"},"description":"V marci 2009 bol u pacientov v Mexiku identifikovan\u00fd nov\u00fd kme\u0148 v\u00edrusu chr\u00edpky typu A, - \u201cprasacia chr\u00edpka\u201d, \u201cnov\u00e1 chr\u00edpka\u201d alebo \u201cH1N1\u201d resp. \u201cA\/H1N1\u201d.","inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843"]}]},{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/slanedeti.sk\/cms\/chripka-h1n1-a-cf-2\/843#primaryimage","url":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2013\/07\/logo_CB-e1446396108362.png","contentUrl":"https:\/\/slanedeti.sk\/cms\/wp-content\/uploads\/2013\/07\/logo_CB-e1446396108362.png","width":350,"height":350},{"@type":"WebSite","@id":"https:\/\/slanedeti.sk\/cms\/#website","url":"https:\/\/slanedeti.sk\/cms\/","name":"Slan\u00e9 deti","description":"Inform\u00e1cie o cystickej fibr\u00f3ze","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/slanedeti.sk\/cms\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sk-SK"},{"@type":"Person","@id":"https:\/\/slanedeti.sk\/cms\/#\/schema\/person\/05d1c3faf9ab837ae66dc01f490cedaa","name":"Gallagher","url":"https:\/\/slanedeti.sk\/cms\/author\/gallagher"}]}},"_links":{"self":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts\/843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/comments?post=843"}],"version-history":[{"count":0,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/posts\/843\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/media\/1600"}],"wp:attachment":[{"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/media?parent=843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/categories?post=843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/slanedeti.sk\/cms\/wp-json\/wp\/v2\/tags?post=843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}